QIM
LJPC

Quantitative Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Quantitative Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,800
Closed -$637K – 1002
2017
Q4 		$637K Sell
19,800
-128,100
-87% -$4.19M 0.01% 649
2017
Q3 		$5.14M Buy
147,900
+26,100
+21% +$839K 0.06% 327
2017
Q2 		$3.63M Buy
+121,800
New +$3.49M 0.05% 396

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Quantitative Investment Management's LJPC Position: Q1 2018 in Review

Quantitative Investment Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2018, closing a stake of 19,800 shares — an estimated $637K sold.

Quantitative Investment Management first reported a position in LJPC in Q2 2017 and held it in 3 quarters. The position peaked at $5.14M in Q3 2017. 100 funds tracked by Wall St. Rank hold LJPC as of Q1 2018.

  • Quantitative Investment Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 19,800 La Jolla Pharmaceutical Company shares in Q1 2018, an estimated $637K.
  • Quantitative Investment Management first reported a position in La Jolla Pharmaceutical Company in Q2 2017 and held it in 3 quarters.
  • Quantitative Investment Management's La Jolla Pharmaceutical Company position peaked at $5.14M in Q3 2017.
  • 100 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2018.

Based on Quantitative Investment Management's 13F filing for Q1 2018, filed 15 May 2018.